Literature DB >> 6119902

Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy.

R L Stevens, A L Fluharty, H Kihara, M M Kaback, L J Shapiro, B Marsh, K Sandhoff, G Fischer.   

Abstract

Two siblings of consanguineous parents had presented with a variety of findings indicative of juvenile metachromatic leukodystrophy (MLD). However, instead of the expected profound deficiency of arylsulfatase A (ARS A), their enzyme levels were about half-normal, and enzyme from fibroblasts had properties identical with the properties of enzyme from normal fibroblasts. Nevertheless, the hydrolysis of cerebroside sulfate by growing fibroblasts was markedly attenuated. Supplementation of the fibroblasts with cerebroside sulfatase activator normalized the response in the loading test. These results imply that the fibroblasts, and by extension the patients, are deficient in activator. Although the defective catabolism of cerebroside sulfate and the clinical manifestations in these patients mimic MLD, the molecular basis is distinct from the classical forms of the disorder.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119902      PMCID: PMC1685162     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  22 in total

1.  Low molecular weight proteins in secondary lysosomes as activators of different sphingolipid hydrolases.

Authors:  W Mraz; G Fischer; H Jatzkewitz
Journal:  FEBS Lett       Date:  1976-08-01       Impact factor: 4.124

2.  [Activators for sphingohydrolases and the nature of the sphingomyelinase deficiency in Niemann-Pick disease types A, B and C (author's transl)].

Authors:  G Baraton; A Revol
Journal:  Clin Chim Acta       Date:  1977-05-02       Impact factor: 3.786

3.  Cerebroside sulfate hydrolysis by fibroblasts from a parent with metachromatic leukodystrophy.

Authors:  A L Fluharty; R L Stevens; H Kihara
Journal:  J Pediatr       Date:  1978-05       Impact factor: 4.406

4.  The activator of cerebroside-sulphatase. A model of the activation.

Authors:  G Fischer; H Jatzkewitz
Journal:  Biochim Biophys Acta       Date:  1978-01-27

5.  Simplified procedure for preparation of 35S-labeled brain sulfatide.

Authors:  A L Fluharty; M L Davis; H Kihara; G Kritchevsky
Journal:  Lipids       Date:  1974-11       Impact factor: 1.880

6.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.

Authors:  E Conzelmann; K Sandhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

7.  The activator of cerebroside sulphatase. Lysosomal localization.

Authors:  W Mraz; G Fischer; H Jatzkewitz
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-08

8.  The activator of cerebroside sulphatase. Binding studies with enzyme and substrate demonstrating the detergent function of the activator protein.

Authors:  G Fischer; H Jatzkewitz
Journal:  Biochim Biophys Acta       Date:  1977-04-12

9.  An activator stimulating the enzymic hydrolysis of sphingoglycolipids.

Authors:  S C Li; Y T Li
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

10.  Purification and properties of arylsulfatase. A from human urine.

Authors:  R L Stevens; A L Fluharty; M H Skokut; H Kihara
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

View more
  30 in total

1.  Nucleotide sequence of cloned cDNA for human sphingolipid activator protein 1 precursor.

Authors:  N N Dewji; D A Wenger; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Late-onset Krabbe disease initially diagnosed as cerebroside sulfatase activator deficiency.

Authors:  A L Fluharty; L Neidengard; D Holtzman; H Kihara
Journal:  Metab Brain Dis       Date:  1986-09       Impact factor: 3.584

3.  Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes.

Authors:  Diana I Albu; Jeffrey VanValkenburgh; Nicole Morin; Danielle Califano; Nancy A Jenkins; Neal G Copeland; Pentao Liu; Dorina Avram
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

4.  Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder.

Authors:  H Christomanou; A Chabás; T Pámpols; A Guardiola
Journal:  Klin Wochenschr       Date:  1989-10-02

Review 5.  Trafficking of lysosomal enzymes in normal and disease states.

Authors:  S Kornfeld
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

Review 6.  Molecular genetics of metachromatic leukodystrophy.

Authors:  V Gieselmann; A Polten; J Kreysing; K von Figura
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 7.  Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.

Authors:  K Harzer; B C Paton; A Poulos; B Kustermann-Kuhn; W Roggendorf; T Grisar; M Popp
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

8.  Placental steroid deficiency: association with arylsulfatase A deficiency.

Authors:  J Vidgoff; M M Buxman; L J Shapiro; R L Dimond; T G Wilson; C A Hepburn; T Tabei; W R Heinrichs
Journal:  Am J Hum Genet       Date:  1982-05       Impact factor: 11.025

9.  Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency.

Authors:  M A Rafi; S Amini; X L Zhang; D A Wenger
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

10.  Genetic complementation in somatic cell hybrids of cerebroside sulfatase activator deficiency and metachromatic leukodystrophy fibroblasts.

Authors:  H Kihara; K K Tsay; A L Fluharty
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.